|
---|
As Of | Filer | Filing¹ | For·On·As | Docs:Size | Issuer | | Filing Agent | | | | | | | | | |
---|
|
---|
4/18/24 Bizily Scott 4 Officer² 1:10K 4D Molecular Therapeutics, Inc. Donnelley … Solutions/FA
4/3/24 Bizily Scott 4 Officer² 1:15K 4D Molecular Therapeutics, Inc. Donnelley … Solutions/FA
4/1/24 Bizily Scott 144 1:7K 4D Molecular Therapeutics, Inc. Morgan Stanley … Svcs/FA
3/29/24 Bizily Scott 4 Officer² 1:10K 4D Molecular Therapeutics, Inc. Donnelley … Solutions/FA
3/20/24 Bizily Scott 4 Officer² 1:10K 4D Molecular Therapeutics, Inc. Donnelley … Solutions/FA
2/29/24 Bizily Scott 4 Officer² 1:7K 4D Molecular Therapeutics, Inc. Donnelley … Solutions/FA
2/21/24 Bizily Scott 4 Officer² 1:10K 4D Molecular Therapeutics, Inc. Donnelley … Solutions/FA
2/12/24 Bizily Scott 4 Officer² 1:14K 4D Molecular Therapeutics, Inc. Donnelley … Solutions/FA
2/8/24 Bizily Scott 144 1:5K 4D Molecular Therapeutics, Inc. Morgan Stanley … Svcs/FA
12/13/23 Bizily Scott 4 Officer² 1:5K 4D Molecular Therapeutics, Inc. Donnelley … Solutions/FA
6/12/23 Bizily Scott 4 Officer² 1:7K 4D Molecular Therapeutics, Inc. Latham & Watk… Agent)/FA
6/6/23 Bizily Scott 4 Officer² 1:7K 4D Molecular Therapeutics, Inc. Latham & Watk… Agent)/FA
4/25/23 Bizily Scott 4 Officer² 1:7K 4D Molecular Therapeutics, Inc. Broadridge Fin’l So… Inc
4/21/23 Bizily Scott 144 1:5K 4D Molecular Therapeutics, Inc. Morgan Stanley … Svcs/FA
3/3/23 Bizily Scott 4 Officer² 1:7K 4D Molecular Therapeutics, Inc. Broadridge Fin’l… Inc/FA
2/14/23 Bizily Scott 4 Officer² 1:5K 4D Molecular Therapeutics, Inc. Broadridge Fin’l… Inc/FA
12/5/22 Bizily Scott 4 Officer² 1:20K 4D Molecular Therapeutics, Inc. Broadridge Fin’l… Inc/FA
9/6/22 Bizily Scott 4 Officer² 1:5K 4D Molecular Therapeutics, Inc. Broadridge Fin’l… Inc/FA
6/21/22 Bizily Scott 4 Officer² 1:5K 4D Molecular Therapeutics, Inc. Broadridge Fin’l… Inc/FA
3/31/22 Bizily Scott 3 Officer² 2:13K 4D Molecular Therapeutics, Inc. Broadridge Fin’l… Inc/FA
____________ | ¹ | Filing/Form Types: -K | | 3 | Initial Statement of Beneficial Ownership of Securities by an Insider — Form 3 { The Filer is an Insider² of the Issuer }. | | 4 | Statement of Changes in Beneficial Ownership of Securities by an Insider — Form 4 { The Filer is an Insider² of the Issuer }. | | 144 | Notice of a Proposed Sale of Securities by an Insider — Form 144 { The Filer is an Insider² of the Issuer }. | ² | Insider: The Filer is a Director, Officer, 10% Owner and/or Other “insider” of the Issuer. |
|